PUK5 - The economic burden of chronic kidney disease in China

Abstract

PUK5 THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE IN CHINA Wu J1, Yang L2 1Peking University, Beijing, Beijing, China, 2Peking University, Beijing, China OBJECTIVES: Chronic kidney disease (CKD) has been a leading public health problem. The purpose of this study was to evaluate direct and indirect costs of patients with chronic kidney disease in China, producing an average cost per patient per year and the overall economic burden of the whole chronic kidney disease population in China. METHODS: A cost-of-illness analyses was performed. Prevalence data on chronic kidney disease for the Chinese population was collected from literatures. An observational retrospective study was conducted to collect the economic data. We recruited 401 patients diagnosed with chronic kidney disease with 281 patients in 3-4 stage of CKD and 120 patients in the 5th stage of CKD in Beijing, Shanghai, Guangzhou and Chengdu between November 2012 and December2012. Patients or their carers were interviewed about resource utilization and absenteeism from work in the past year.All costs referred to 2012. RESULTS: Among 401 patients with CKD, 56.4% were male and the mean age was 58.0±15.7 years. 94.3% patients in 3-4 stage of CKD and 98.2% patients in the 5th stage of CKD have at least one kind of health insurance. From the societal perspective, total costs per patient over 1 year amounted to Chinese Yuan (CNY) 34205 (median: CNY24246, IQR: CNY16271 CNY 34958) for patients in 3-4 stage of CKD with direct cost accounting for 97.7% of the total, and Chinese Yuan (CNY) 128231 (median: CNY 103450, IQR: CNY 85351 -CNY 159726) for patients in 5th stage of CKD with direct cost accounting for 82.3% of the total. For the direct costs, the outpatient and inpatients visit costs were CNY100374.6 and indirect costs were CNY22687.4. CONCLUSIONS: The economic burden of chronic kidney disease in China is considerable, especially for patients in 1-4 stage of CKD. The primary burden on patients was due to direct medical cost.